F373280
/ Pierre Fabre
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
June 03, 2013
Efficacy and Safety Study of F373280
(clinicaltrials.gov)
- P2 | N=152 | Recruiting | Sponsor: Pierre Fabre Medicament | Not yet recruiting ➔ Recruiting
Enrollment open • Atrial Fibrillation • Cardiovascular • Heart Failure
April 11, 2013
Efficacy and Safety Study of F373280
(clinicaltrials.gov)
- P2 | N=152 | Recruiting | Sponsor: Pierre Fabre Medicament
New P2 trial • Atrial Fibrillation • Cardiovascular • Heart Failure
September 04, 2014
Efficacy and Safety Study of F373280
(clinicaltrials.gov)
- P2 | N=152 | Recruiting | Sponsor: Pierre Fabre Medicament | Trial primary completion date: Jul 2014 ➔ Apr 2016
Trial primary completion date • Atrial Fibrillation • Cardiovascular • Heart Failure
December 05, 2015
Efficacy and Safety Study of F373280
(clinicaltrials.gov)
- P2 | N=152 | Recruiting | Sponsor: Pierre Fabre Medicament | Trial primary completion date: Apr 2016 ➔ Jul 2017
Trial primary completion date • Atrial Fibrillation • Cardiovascular • Heart Failure
November 09, 2016
Efficacy and Safety Study of F373280
(clinicaltrials.gov)
- P2 | N=135 | Active, not recruiting | Sponsor: Pierre Fabre Medicament | Terminated ➔ Active, not recruiting
Enrollment closed • Atrial Fibrillation • Cardiovascular • Heart Failure
October 21, 2016
Efficacy and Safety Study of F373280
(clinicaltrials.gov)
- P2 | N=135 | Terminated | Sponsor: Pierre Fabre Medicament | Recruiting ➔ Terminated
Trial termination • Atrial Fibrillation • Cardiovascular • Heart Failure
November 24, 2017
Efficacy and Safety Study of F373280
(clinicaltrials.gov)
- P2 | N=135 | Completed | Sponsor: Pierre Fabre Medicament | Active, not recruiting ➔ Completed | Trial primary completion date: Sep 2017 ➔ Apr 2017
Trial completion • Trial primary completion date • Atrial Fibrillation • Cardiovascular • Heart Failure
1 to 7
Of
7
Go to page
1